PAST EVENT
SPEAKERS
Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS). His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist.
Robin Carhart-Harris, PhD, is an esteemed neuropharmacologist, psychologist, and became the Ralph Metzner Distinguished Professor in Neurology and Psychiatry at the University of California, San Francisco in 2021. His current research program is focused on the mechanisms of action of psychedelics and psychedelic-therapy. Dr. Carhart-Harris was named among the top 31 medical scientists by The Times newspaper in 2020, listed in TIME magazine’s “100 Next” in 2021, voted psychedelic researcher of the year in 2021.
Dr. Adi Zuloff-Shani is a biomedical research and development executive with over 20 years of strategic and operational leadership in the healthcare industry, and a deep understanding of therapeutics development in heavily regulated environments.
Previously the Executive Director of MAPS Canada for 10 years, Mark is an adjunct professor at the University of British Columbia's School of Population and Public Health, and has published on the issue of drug control policy and psychedelics. Mark also worked in the addictions field in counselling, supervisory and management positions for 28 years.
HOST
Shannon Smadella is an award-winning social entrepreneur and business strategist with deep experience in psychedelic advocacy and organizational leadership. A former board member of MAPS Canada, spokesperson and operations director of World Psychedelics Day, and co-director of the International Psychedelics Awareness Foundation, she has hosted hundreds of interviews with leaders in psychedelic research and policy. She is currently completing her MBA, and oversees community development for Clearmind Medicine.